Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drisapersen in ambulant Duchenne muscular dystrophy
NCT01153932Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Mar 2012
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial of drisapersen in Duchenne muscular dystrophy (DMD), sponsored by GSK. Started Sep 2010; status: completed.
02
Drugs
drisapersen
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01153932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01153932.